Advertisement

Topics

Athersys Company Profile

13:32 EST 23rd February 2017 | BioPortfolio

Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases.
As represented by its name, (Athersys - derived from advanced therapeutic systems), the Company is committed to developing novel therapeutic products that deliver substantial improvements over existing therapies through the application and utilization of its advanced, proprietary technology platforms.

Through internal development and acquisition of key technologies, Athersys has established a unique blend of competencies in areas such as molecular biology, cell biology, genomics, protein biochemistry, medicinal chemistry, and pharmacology. The Company has fully integrated pre-clinical drug discovery and development capabilities, and is focused on advancing a portfolio of therapeutic development programs into the clinic.

Location

3201 Carnegie Avenue
Cleveland
Ohio
44115-2634
United States of America

Contact

Phone: 216-431-9900
Fax: 216-361-9495
Email: jobs@athersys.com., ir@athersys.com


News Articles [24 Associated News Articles listed on BioPortfolio]

Biotech Athersys nets $18.6mm in FOPO

Athersys Inc. (off-the-shelf cell therapy) netted $18.6mm in a follow-on public offering of 19.8mm common shares at $1.01. The company will use the proceeds to fund its Phase III MultiStem Administra...

Biotech Athersys nets $21.4mm in FOPO

Athersys Inc. (off-the-shelf cell therapy) netted $21.4mm in a follow-on public offering of 22.8mm common shares (including full exercise of the over-allotment option) at $1.01. The company will use ...

Athersys (ATHX) - Progress on all fronts

Edison Investment Research - Pharmaceutical & healthcare - Athersys: Recently, Athersys reported progress with both US and Japanese regulatory authorities. The company reached a deal with the FDA for ...

BRIEF-Athersys, FDA agree on design for ischemic stroke late-stage study

* Athersys receives FDA agreement under special protocol assessment for phase 3 study of multistem treatment for ischemic stroke Source text for Eikon: Further company coverage:

BRIEF-Athersys reports pricing of public offering of common stock

* Athersys announces pricing of public offering of common stock Source text for Eikon: Further company coverage:

Athersys completes follow-on

Athersys: An In-Depth Discussion With CEO Dr. Gil Van Bokkelen

The Troubled Reality Of An Athersys Shareholder

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Athersys Incorporated

Athersys is a biotechnology company engaged in the research and development of products for the treatment and diagnosis of genetic and immunologic disorders. The company has a core expertise in the f...

Athersys

Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases.As represented by its name, (Ather...

Athersys, Inc.

Athersys is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company ...

More Information about "Athersys" on BioPortfolio

We have published hundreds of Athersys news stories on BioPortfolio along with dozens of Athersys Clinical Trials and PubMed Articles about Athersys for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Athersys Companies in our database. You can also find out about relevant Athersys Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record